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CASE REPORT 
ACUTE GOUTY ARTHRITIS AS A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY 
SYNDROME AFTER INITIATION OF ANTIRETROVIRAL THERAPY 
Walter de Araujo EYER-SILVA(1), Maria Cecília da Fonseca SALGADO(1), Jorge Francisco da Cunha PINTO(1), Fernando Raphael de Almeida FERRY(1),  
Rogério NEVES-MOTTA(1), Marcelo Costa Velho Mendes de AZEVEDO(1) & Carlos Alberto MORAIS-DE-SÁ(1)
SUMMARY
Immune reconstitution inflammatory syndrome (IRIS) in HIV-infected subjects initiating antiretroviral therapy most commonly 
involves new or worsening manifestations of previously subclinical or overt infectious diseases. Reports of non-infectious IRIS are much 
less common but represent important diagnostic and treatment challenges. We report on a 34-year-old HIV-infected male patient with 
no history of gout who developed acute gouty arthritis in a single joint one month after initiating highly active antiretroviral therapy.
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INTRODUCTION
Reports of unusual symptoms and signs appearing in HIV-infected 
patients soon after initiation of antiretroviral therapy and associated 
with increasing CD4 cell counts have been reported since the advent of 
highly active antiretroviral therapy (HAART). This paradoxical clinical 
worsening, which has been termed immune reconstitution inflammatory 
syndrome (IRIS), most commonly involves new or worsening 
manifestations of previously subclinical or overt infectious diseases 
such as tuberculosis, Mycobacterium avium infections, cryptococcal 
meningitis, herpes zoster and cytomegalovirus disease5. Reports of 
non-infectious IRIS are much less common but represent important 
diagnostic and treatment challenges. We report on a patient who had 
no history of articular disease who developed gouty arthritis in a single 
joint after initiating HAART.
CASE REPORT
A previously asymptomatic, mildly overweight 34-year-old HIV 
infected male was started on a highly active antiretroviral regimen 
(lamivudine, tenofovir, atazanavir and ritonavir) due to a progressive 
decline of CD4 cell counts. At the time of HAART initiation his CD4 cell 
count was 166 cells/mm3 (a drop from 680 cells/mm3 to 166 cells/mm3 
had been recorded in an 18-month period). Three weeks after initiation 
of HAART he presented with an abrupt onset of severe pain, redness 
and swelling in the area of the first right metatarsophalangeal joint. He 
complained of exquisite soft tissue tenderness to the point that he could 
not put on his right shoe. Laboratory evaluation was remarkable for mild 
hyperuricemia (7.7mg/dL; normal range 3.5-7.2mg/dL; uric acid urinary 
excretion was not measured). Serum uric acid had not been measured 
before the acute gout presentation. No abnormalities were found on plain 
radiology. The patient had no past history of gout or other rheumatological 
disorders, but informed that his father was a long-term gout sufferer. He 
also had no history of urolithiasis and was not under any other medication 
besides HAART and sulphametoxazole/trimethoprim thrice weekly. 
General measures of rest, a low-purine diet, and avoidance of alcohol intake 
were instituted. Colchicine and a nonsteroidal anti-inflammatory drug were 
started with slow resolution over the ensuing three months. During this 
period the patient experienced disabling, ongoing symptoms with intense 
inflammation, desquamation and a toothpaste-like, chalky discharge (Fig. 
1). Despite the severity of the presentation and its temporal association with 
the initiation of the antiviral regimen, a decision was made not to interrupt 
HAART. Allopurinol was initiated one month after the acute presentation 
and a better clinical control was achieved. A progressive recovery of the 
CD4 cell count was recorded: 306 cells/mm3 and 459 cells/mm3 two and 
five months after initiation of HAART, respectively. The plasma HIV 
viral load dropped from 817.111 copies/mL to 57 copies/mL before and 
five months after HAART initiation, respectively. Six months after the 
acute presentation the patient still experienced gout flares associated with 
binge alcohol consumption (mainly beer) and non compliance with the 
prescribed diet. One year after presentation the patient was asymptomatic. 
No other joint has ever been affected. The serum uric acid returned to 
normal levels (7.2 mg/dL and 4.0 mg/dL, one and five months after acute 
gout presentation, respectively).
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DISCUSSION
Non-infectious IRIS cases are being reported much less frequently 
than the clinical worsening or the unmasking of infectious disorders. One 
of the first such cases was reported in 19981 from a 36 year-old woman 
who developed systemic lupus erythematosus associated with rising 
antinuclear antibody titers after initiation of HAART. Since then, a variety 
of non-infectious IRIS cases have been reported, including sarcoidosis7, 
lymphoid pneumonitis7, cutaneous reaction to tattoo pigment11, alopecia 
universalis and Graves disease10, rheumatoid arthritis2, and Guillain-Barré 
syndrome8. SEBENY et al.9 have previously reported on a 53-year-old 
HIV-infected male patient with a history of intermittent attacks of 
gout who developed severe polyarticular gouty arthritis one week after 
initiation of a HAART regimen consisting of tenofovir, emtricitabine 
and efavirenz.
Gout has rarely been reported in association with HIV infection4. 
The present case shares resemblance to the previously reported patient 
who presented with polyarticular gouty arthritis as a manifestation of 
IRIS9. In contrast to the case reported by SEBENY et al.9, our patient 
had no prior history of gout and presented with monoarticular disease. 
Interestingly, he presented a relentless acute gout syndrome associated 
with exquisite pain that lasted three months and went on to develop 
signs of a draining tophus, which is uncommon in patients without prior 
signs and symptoms of gout. It has been suggested that improvements in 
neutrophil function and decreasing levels of the anti-inflammatory IL-10 
cytokine after initiation of HAART may result in a restored ability to react 
against monosodium urate crystals9. The effect of individual antiretroviral 
agents on uric acid metabolism should also be considered. It is known 
that the nucleoside analogs stavudine and didanosine are associated with 
hyperuricemia, whereas the nucleotide analog tenofovir seems to lower 
serum uric acid12. It has also been suggested that ritonavir-including 
regimens may be associated with an increased risk of hyperuricemia 
and gout3,6.
Physicians caring for HIV-infected patients should be aware that 
severe acute gouty arthritis may emerge as a non-infectious manifestation 
of IRIS in HIV-infected patients initiating HAART.
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RESUMO 
Gota aguda como manifestação da síndrome inflamatória de 
reconstituição imune após início de terapia antirretroviral
A síndrome inflamatória da reconstituição imune (IRIS) observada 
quando do início da terapia antirretroviral em indivíduos com infecção 
pelo HIV envolve mais comumente manifestações novas ou piora clínica 
de desordens infecciosas, previamente subclínicas ou não. Muito mais 
raras são as descrições de casos de IRIS de natureza não-infecciosa, 
embora representem importantes desafios ao diagnóstico e tratamento. 
Neste relato descrevemos um paciente HIV-positivo do sexo masculino, 
de 34 anos, sem antecedentes de gota e que desenvolveu monoartrite 
de gota um mês após início de terapia antirretroviral de alta atividade.
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Fig. 2 - Marked resolution three months after acute presentation. 
Fig. 1 - Severe acute gouty arthritis of the first right metatarsophalangeal joint in a 34-year-old 
HIV-infected male patient. This image was taken one month after acute gout presentation. 
Intense redness and shiny swelling with skin desquamation can be seen. The lesion was warm, 
exquisitely tender and an eventual chalky discharge erupted. 
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